Sponsors: []Modifications:      31A-22-623.5.(1)  As used in this section:(a)  "Amino acid-based elemental formula" means a nutrition formula:(i)  made from individual nonallergenic amino acids that are broken down to enhanceabsorption and digestion; and(ii)  designed for individuals who have a dysfunctional or shortened gastrointestinaltract and are unable to tolerate and absorb whole foods or formulas composed of wholeproteins, fats, or carbohydrates.(b)  "Eosinophilic gastrointestinal disorder" means a disorder characterized by havingabove normal amounts of eosinophils in one or more specific places anywhere in the digestivesystem.(c)  "Food protein-induced enterocolitis syndrome" means a disorder characterized byan  abnormal immune response to an ingested food, resulting in gastrointestinal inflammation.(d)  "Health insurer" means an insurer, as defined in Subsection 31A-22-634(1).(e)  "Order" means to communicate orally, in writing, or by electronic means.(f)  "Pharmacy" means a pharmacy licensed under Title 58, Chapter 17b, PharmacyPractice Act.(g)  "Physician" means an individual who is licensed under Title 58, Chapter 67, UtahMedical Practice Act, or Title 58, Chapter 68, Utah Osteopathic Medical Practice Act.(h)  "Severe protein allergic conditions" includes:(i)  eosinophilic esophagitis;(ii)  eosinophilic gastritis;(iii)  eosinophilic gastroenteritis;(iv)  eosinophilic enteritis;(v)  eosinophilic colitis;(vi)  immunoglobulin E-mediated allergies to multiple food proteins;(vii)  nonimmunoglobulin E-mediated allergies to multiple food proteins; or(viii)  food protein-induced enterocolitis syndrome.(i)  "Short bowel syndrome" means malabsorption of nutrients resulting fromanatomical or functional loss of a significant length of the small intestine.(2)  A health insurer shall offer to a potential purchaser at least one health benefit planthat provides coverage for the use of an amino acid-based elemental formula, regardless of thedelivery method of the formula, for the diagnosis or treatment of an eosinophilicgastrointestinal disorder, food protein-induced enterocolitis syndrome, severe protein allergiccondition, or short bowel syndrome.(3)  Coverage offered under Subsection (2) applies to an amino acid-based elementalformula if:(a)  the formula is ordered for the enrollee by a physician;(b)  the physician indicates in the order that the formula is medically necessary; and(c)  the insured obtains the formula from a pharmacy.(4)  Coverage offered under Subsection (2) may not include cost-sharing provisions,including deductibles, copayments, co-insurance, and out-of-pocket limits, or a durationallimit, that are less favorable to the insured than the cost-sharing provisions and durationallimits applied by the health benefit plan to prescription drugs.Full text:



1     COVERAGE PARITY FOR AMINO ACID-BASED FORMULA2     2017 GENERAL SESSION3     STATE OF UTAH4     Chief Sponsor:  Edward H. Redd5     Senate Sponsor:  ____________6      7     LONG TITLE8     General Description:9          This bill amends the Insurance Code.10     Highlighted Provisions:11          This bill:12                provides definitions;13                requires a health insurer to offer at least one plan that covers amino acid-based14     elemental formula for the diagnosis or treatment of an eosinophilic gastrointestinal15     disorder, food protein-induced enterocolitis syndrome, severe protein allergic16     condition, or short bowel syndrome;17                limits coverage to formula ordered by a physician and obtained from a pharmacy;18     and19                prohibits cost sharing for elemental formula that is less favorable to the insured than20     cost sharing for prescription drugs.21     Money Appropriated in this Bill:22          None23     Other Special Clauses:24          None25     Utah Code Sections Affected:26     ENACTS:27          31A-22-623.5, Utah Code Annotated 195328      29     Be it enacted by the Legislature of the state of Utah:30          Section 1.  Section 31A-22-623.5 is enacted to read:31          31A-22-623.5. Insurance coverage for amino acid-based formula.32          (1)  As used in this section:33          (a)  "Amino acid-based elemental formula" means a nutrition formula:34          (i)  made from individual nonallergenic amino acids that are broken down to enhance35     absorption and digestion; and36          (ii)  designed for individuals who have a dysfunctional or shortened gastrointestinal37     tract and are unable to tolerate and absorb whole foods or formulas composed of whole38     proteins, fats, or carbohydrates.39          (b)  "Eosinophilic gastrointestinal disorder" means a disorder characterized by having40     above normal amounts of eosinophils in one or more specific places anywhere in the digestive41     system.42          (c)  "Food protein-induced enterocolitis syndrome" means a disorder characterized by43     an  abnormal immune response to an ingested food, resulting in gastrointestinal inflammation.44          (d)  "Health insurer" means an insurer, as defined in Subsection 31A-22-634(1).45          (e)  "Order" means to communicate orally, in writing, or by electronic means.46          (f)  "Pharmacy" means a pharmacy licensed under Title 58, Chapter 17b, Pharmacy47     Practice Act.48          (g)  "Physician" means an individual who is licensed under Title 58, Chapter 67, Utah49     Medical Practice Act, or Title 58, Chapter 68, Utah Osteopathic Medical Practice Act.50          (h)  "Severe protein allergic conditions" includes:51          (i)  eosinophilic esophagitis;52          (ii)  eosinophilic gastritis;53          (iii)  eosinophilic gastroenteritis;54          (iv)  eosinophilic enteritis;55          (v)  eosinophilic colitis;56          (vi)  immunoglobulin E-mediated allergies to multiple food proteins;57          (vii)  nonimmunoglobulin E-mediated allergies to multiple food proteins; or58          (viii)  food protein-induced enterocolitis syndrome.59          (i)  "Short bowel syndrome" means malabsorption of nutrients resulting from60     anatomical or functional loss of a significant length of the small intestine.61          (2)  A health insurer shall offer to a potential purchaser at least one health benefit plan62     that provides coverage for the use of an amino acid-based elemental formula, regardless of the63     delivery method of the formula, for the diagnosis or treatment of an eosinophilic64     gastrointestinal disorder, food protein-induced enterocolitis syndrome, severe protein allergic65     condition, or short bowel syndrome.66          (3)  Coverage offered under Subsection (2) applies to an amino acid-based elemental67     formula if:68          (a)  the formula is ordered for the enrollee by a physician;69          (b)  the physician indicates in the order that the formula is medically necessary; and70          (c)  the insured obtains the formula from a pharmacy.71          (4)  Coverage offered under Subsection (2) may not include cost-sharing provisions,72     including deductibles, copayments, co-insurance, and out-of-pocket limits, or a durational73     limit, that are less favorable to the insured than the cost-sharing provisions and durational74     limits applied by the health benefit plan to prescription drugs.Legislative Review NoteOffice of Legislative Research and General Counsel

